Retinoic acid receptors: from molecular mechanisms to cancer therapy

A Di Masi, L Leboffe, E De Marinis, F Pagano… - Molecular aspects of …, 2015 - Elsevier
Retinoic acid (RA), the major bioactive metabolite of retinol or vitamin A, induces a spectrum
of pleiotropic effects in cell growth and differentiation that are relevant for embryonic …

Retinoids, retinoic acid receptors, and cancer

XH Tang, LJ Gudas - Annual Review of Pathology: Mechanisms …, 2011 - annualreviews.org
Retinoids (ie, vitamin A, all-trans retinoic acid, and related signaling molecules) induce the
differentiation of various types of stem cells. Nuclear retinoic acid receptors mediate most but …

GSVA: gene set variation analysis for microarray and RNA-seq data

S Hänzelmann, R Castelo, J Guinney - BMC bioinformatics, 2013 - Springer
Background Gene set enrichment (GSE) analysis is a popular framework for condensing
information from gene expression profiles into a pathway or signature summary. The …

Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

T Schenk, WC Chen, S Göllner, L Howell, L Jin… - Nature medicine, 2012 - nature.com
Acute promyelocytic leukemia (APL), a cytogenetically distinct subtype of acute myeloid
leukemia (AML), characterized by the t (15; 17)-associated PML-RARA fusion, has been …

The success and the challenge of all-trans retinoic acid in the treatment of cancer

X Ni, G Hu, X Cai - Critical reviews in food science and nutrition, 2019 - Taylor & Francis
All-trans retinoic acid (ATRA), an active metabolite of vitamin A, plays important roles in cell
proliferation, cell differentiation, apoptosis, and embryonic development. The effects of ATRA …

Unlocking the potential of retinoic acid in anticancer therapy

T Schenk, S Stengel, A Zelent - British journal of cancer, 2014 - nature.com
All-trans-retinoic acid (ATRA) is a physiologically active metabolite of vitamin A. Its
antitumour activities have been extensively studied in a variety of model systems and clinical …

Differentiation therapy of acute myeloid leukemia: past, present and future

K Petrie, A Zelent, S Waxman - Current opinion in hematology, 2009 - journals.lww.com
Here, we examine the reasons why the exquisite sensitivity of APL to ATRA-based
differentiation therapy has not been extended to other of AML subtypes. Current …

Retinoic acid receptors in acute myeloid leukemia therapy

O di Martino, JS Welch - Cancers, 2019 - mdpi.com
Retinoic acid (RA) signaling pathways regulate fundamental biological processes, such as
cell proliferation, development, differentiation, and apoptosis. Retinoid receptors (RARs and …

Clinical responsiveness to all-trans retinoic acid is potentiated by LSD1 inhibition and associated with a quiescent transcriptome in myeloid malignancies

MM Tayari, HGD Santos, D Kwon, TJ Bradley… - Clinical Cancer …, 2021 - AACR
Purpose: In preclinical studies, the lysine-specific histone demethylase 1A (LSD1) inhibitor
tranylcypromine (TCP) combined with all-trans retinoic acid (ATRA) induces differentiation …

Cigarette smoke-induced alterations in blood: A review of research on DNA methylation and gene expression.

CP Silva, HM Kamens - Experimental and clinical …, 2021 - psycnet.apa.org
Worldwide, smoking remains a threat to public health, causing preventable diseases and
premature mortality. Cigarette smoke is a powerful inducer of DNA methylation and gene …